Institute of Medical Research, Northweastern Polytechnical University, Xi'an, 710072, People's Republic of China.
Department of Physiology and Pathophysiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
Cardiovasc Toxicol. 2021 Jan;21(1):2-11. doi: 10.1007/s12012-020-09609-y. Epub 2020 Oct 1.
The MG53 (also known as TRIM72) is a conserved, muscle-specific tripartite motif family protein that is abundantly expressed in cardiac or skeletal muscle and present in circulation. Recently, the MG53 had been hypothesized to serve a dual role in the heart: involving in repairing cell membranes that protect myocardial function while acting as an E3 ligase to trigger insulin resistance and cardiovascular complications. This review discusses the roles of MG53 in cardiac physiological function with emphasis on MG53 protective function in the heart and its negative impact on the myocardium due to the continuous elevation of MG53. Besides, this work reviewed the significance of MG53 as a potential therapeutic in human cardiovascular diseases. Despite the expression of MG53 being rare in the human, thus exogenous MG53 can potentially be a new treatment for human cardiovascular diseases. Notably, the specific mechanism of MG53 in cardiovascular diseases remains elusive.
肌球蛋白重链结合蛋白 53(也称为 TRIM72)是一种保守的、肌肉特异性三联基序家族蛋白,在心脏或骨骼肌中大量表达,并存在于循环中。最近,MG53 被假设在心脏中具有双重作用:参与修复保护心肌功能的细胞膜,同时作为 E3 连接酶触发胰岛素抵抗和心血管并发症。本文讨论了 MG53 在心脏生理功能中的作用,重点介绍了 MG53 在心脏中的保护作用及其由于 MG53 的持续升高对心肌的负面影响。此外,本文还综述了 MG53 作为人类心血管疾病潜在治疗靶点的意义。尽管 MG53 在人体中的表达罕见,因此外源性 MG53 可能成为人类心血管疾病的一种新的治疗方法。值得注意的是,MG53 在心血管疾病中的具体机制仍不清楚。